Biogen and Ionis Pharmaceuticals Report Nusinersen Meets Primary Endpoint at Interim Analysis of Phase 3 ENDEAR Study in Infantile-Onset Spinal Muscular Atrophy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AAPL
6. HOOD
7. QCOM
8. ACN
9. AZN
10. ROIV

Go back to Biogen and Ionis Pharmaceuticals Report Nusinersen Meets Primary Endpoint at Interim Analysis of Phase 3 ENDEAR Study in Infantile-Onset Spinal Muscular Atrophy
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 212.50 -8.33 (3.77%)
Previous Close $220.83    52 Week High $333.65 
Open $215.45    52 Week Low $223.02 
Day High $217.28    P/E 27.21 
Day Low $210.54    EPS $7.81 
Volume 617,826       

(NASDAQ: IONS) Delayed: 56.71 -1.38 (2.38%)
Previous Close $58.09    52 Week High $62.68 
Open $52.15    52 Week Low $19.59 
Day High $57.43    P/E N/A 
Day Low $52.15    EPS $0.00 
Volume 9,175,678